Funder: National Institutes of Health

Due Dates: June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | February 5, 2026 (New) | March 5, 2026 (Renewal/Resubmission/Revision) | June 5, 2026 (New) | July 5, 2026 (Renewal/Resubmission/Revision) | October 5, 2026 (New) | November 5, 2026 (Renewal/Resubmission/Revision) | February 5, 2027 (New) | March 5, 2027 (Renewal/Resubmission/Revision) | June 5, 2027 (New) | July 5, 2027 (Renewal/Resubmission/Revision)

Funding Amounts: No budget cap; typical R01 duration up to 5 years; budgets must reflect actual project needs.

Summary: Supports multi-level and/or multi-domain intervention research to reduce disparities in liver diseases and liver cancer among U.S. populations experiencing health disparities.

Key Information: Clinical trials are optional; simplified review criteria apply for due dates after January 25, 2025; NCI will not consider proposals >$500,000 direct costs/year.